# CfDNA in Hereditary And High-risk Malignancies 2

> **NCT06726642** · — · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 1000 (estimated)

## Conditions studied

- Hereditary Cancer Syndrome

## Interventions

- **DIAGNOSTIC_TEST:** Cell-free DNA analysis

## Key facts

- **NCT ID:** NCT06726642
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-19
- **Primary completion:** 2029-12
- **Final completion:** 2031-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-12-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06726642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06726642, "CfDNA in Hereditary And High-risk Malignancies 2". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06726642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*